Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kraig Biocraft Laboratories Inc KBLB

Kraig Biocraft Laboratories, Inc. develops fibers using recombinant deoxyribonucleic acid (DNA) technology for commercial applications in technical textiles. The Company uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its primary fiber technology includes natural and engineered variants of spider silk produced from domesticated... see more

OTCQB:KBLB - Post Discussion

Kraig Biocraft Laboratories Inc > Kraig Biocraft Laboratories (OTCQB: KBLB) Welcomes New Begin
View:
Post by whytestocks on Jan 30, 2024 10:45am

Kraig Biocraft Laboratories (OTCQB: KBLB) Welcomes New Begin

Just In: $KBLB Kraig Biocraft Laboratories (OTCQB: KBLB) Welcomes New Beginnings2024-01-30 09:53:25 ET DENVER, Colo., Jan. 30, 2024 ( www.247marketnews.com )- Michigan based Kraig Biocraft Laboratories (OTCQB: KBLB) just reported that it’s ramping up new production trial runs, on the heels of the early production tests that the company performed and announce...KBLB - Kraig Biocraft Laboratories (OTCQB: KBLB) Welcomes New Beginnings
Be the first to comment on this post